Member ofNvidia Inception Program

Search for Dr. Catherine Hren, Md, Dermatology, Cary, NC.

Bot
Bot

The search results for your inquiry are provided below, along with Sources for further clarification.

Overview
Practice
About
FAQ
info
share

Dr. Catherine Hren, Mdverified

Checkmark IconAccepts new patients
Is this you? Manage your online reputation
Please wait while we find reviews for your provider...
Specialty iconSpecialties
Dermatology
ArrowDownIcon
Location iconLocationCary, NC
Bioicon
Bio:
Discover compassionate dermatological care with a dedicated expert, br...
Experienceicon
Experience:
30+ years
Languages Spokenicon
Languages Spoken:
English
[9]
Common Treatmentsicon
Common Treatments:
Acne
Eczema
Psoriasis
See More
Institutes Attendedicon
Institutes Attended:
DUSM, 
DUH, 
ABD
Certificatesicon
Certificates:
MD, 
Intern, 
Res
[9]
NPI/License numbericon
NPI/License number:
1508851478
Hospital Affiliationsicon
Hospital Affiliations:
University of North Carolina Hospital
See More
Sexicon
Sex:
female
This is an AZ search result. This provider is not affiliated, endorsing or endorsed by AZcare, Please verify key information.
specSources:

[1]

Reference Icon
Aetnawww.aetna.com

[2]

Reference Icon
Ambetterhealthguide.ambetterhealth.com

[3]

Reference Icon
Bcbsmwww.bcbsm.com
Common Treatmentsicon
Common Treatments:
Acne
Eczema
Psoriasis
Skin Cancer
Melanoma
Basal Cell Carcinoma
Squamous Cell Carcinoma of Skin
See More
Institutes Attendedicon
Institutes Attended:
DUSM, 
DUH, 
ABD
Certificatesicon
Certificates:
MD, 
Intern, 
Res
[9]
NPI/License numbericon
NPI/License number:
1508851478
Hospital Affiliationsicon
Hospital Affiliations:
University of North Carolina Hospital
See More
Sexicon
Sex:
female
specOverview
Dr. Catherine Hren is a highly respected, board-certified dermatologist with over 32 years of experience. A graduate of Duke University School of Medicine, she is affiliated with both WakeMed Cary Hospital and the University of North Carolina Hospital, ensuring her patients have access to exceptional care. Dr....
specPractice
insurance
In-network insurance
[3][1]
Aetna
Alliant Health Plans
Ambetter
Aspire Health Plan
Blue Cross Blue Shield
Blue Cross Blue Shield of Kansas City

Insurance info is for reference only. Contact the provider to confirm they accept your plan, as some may decline certain insurances even if technically in-network.

insurance
Appointments Scheduling
[9]
Cary Dermatology Center PA
Avatar iconIn-Person Visit
location icon

Address:

101 SW Cary Pkwy Ste 210, Cary, NC 27511
phone Icon

Phone:

(919) 467-8556
faxIcon

Fax:

(919) 380-1480

specAbout
NPI/License numbericon
NPI/License number:
1508851478
[8]
Experienceicon
Experience:
30+ years
Languages Spokenicon
Languages Spoken:
English
[9]
Hospital Affiliationsicon
Hospital Affiliations:
[9]
University of North Carolina Hospital
Wakemed Cary Hospital
Specialtiesicon
Specialties:
Dermatology
General Dermatology
Common Treatmentsicon
Common Treatments:
Acne
See More
Education IconEducation & Certifications:
Education Icon
Residency in Dermatology
Duke University Hospital1995
Education Icon
Board Certification in Dermatology
American Board of Dermatology1995
Education Icon
Internship in Internal Medicine
Duke University Hospital1992
Education Icon
Medical Degree
Duke University School of Medicine1991
See More
Education IconPublications:
Publication Icon
Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
This study evaluated the clinical performance and utility of a noninvasive gene expression assay, the pigmented lesion assay (PLA), in routine dermatology practice for assessing melanoma risk in pigmented skin lesions. The PLA detects expression of two genes, LINC00518 and PRAME, associated with melanoma, using adhesive patch sampling, aiming to reduce unnecessary biopsies. Retrospective analysis of 381 patients (51 PLA-positive and 330 PLA-negative) across four US dermatology sites showed that 100% of PLA-positive lesions underwent biopsy, identifying 19 melanomas (all early stage, in situ or stage 1), yielding a number needed to biopsy (NNB) of 2.7 and a biopsy ratio of 1.7 benign lesions per melanoma. Meanwhile, 99% of PLA-negative lesions were managed by surveillance, with no melanomas detected in follow-up biopsies. The PLA demonstrated estimated sensitivity of 95%, specificity of 91%, and a negative predictive value (NPV) exceeding 99%, outperforming the traditional visual assessment and histopathology (VAH) pathway which has lower sensitivity (~84%) and specificity (<30%). Dual positivity for LINC and PRAME correlated strongly (93%) with melanoma diagnosis, while single-gene positives were less predictive. The study highlights PLA’s ability to guide clinicians in biopsy decisions, significantly reducing unnecessary biopsies and excisions while maintaining high melanoma detection rates. Limitations include the assumption that unbiopsied PLA-negative lesions are true negatives and a lower melanoma prevalence in the cohort, but ongoing extended follow-up studies aim to address these. Overall, PLA offers a noninvasive, objective, and accurate tool that transforms melanoma risk assessment from subjective and invasive toward precise and patient-friendly clinical management.
By Laura K. Ferris + 7 more
01-10-2018
Education IconReviews

Aggregated Ratings: 4.4

Positive feedback

Neutral feedback

Negative feedback

  • • Dr. Hren treats patients with patience and respect.
  • • She is personable and shares jokes, which builds trust.
  • • Highly professional and recommended over other dermatologists.
  • • Conducts thorough body checkups and explains treatment steps.
  • • Her friendly demeanor makes visits enjoyable.
  • • Effective treatment recommendation led to successful results.
  • • Went above and beyond by treating patients even on her day off.
  • • Cares for patients as individuals, not just as cases.
  • • Genuine and caring during appointments, providing a great experience.
  • • Efficient staff and no rush during consultations.
    No neutral feedback were found
    No negative feedback were found
specFAQ

Dr. Hren treats acne, eczema, psoriasis, skin cancer, melanoma, rosacea, dermatitis, warts, moles, skin infections, and various other skin conditions.

She performs skin cancer removal, destruction of benign/malignant lesions, skin biopsies, wart treatment, shaving of skin lesions, and excision of skin growths.

Yes, she specializes in detecting and treating skin cancers including melanoma, basal cell carcinoma, and squamous cell carcinoma.

She treats cosmetic concerns and performs procedures for skin rejuvenation and improvement.

Yes, she provides annual skin checks, preventive screenings, and evaluation of changing moles and suspicious lesions.

She practices at Cary Dermatology Center PA, 101 SW Cary Pkwy Suite 210, Cary, NC 27511.

She earned her MD from Duke University School of Medicine (1991), completed internal medicine internship (1991-1992) and dermatology residency (1992-1995) at Duke University Hospital.

Dr. Hren speaks English.

She accepts Aetna, Blue Cross Blue Shield, Cigna, Humana, First Health, Delta Dental, Curative, UnitedHealthcare and other major plans.

Patients praise her thorough care and friendly demeanor, with an average rating of 4.37 out of 5 from 192 reviews.

Common Questions

What are the best skincare products for acne-prone skin?

How often should I exfoliate my skin?

What is the difference between a chemical peel and a microdermabrasion treatment?

Can you recommend any skincare routines for hyperpigmentation?

How do I prevent ingrown hairs on my face and body?